German Cancer Research Center (DKFZ)
Deutsches Krebsforschungszentrum
General information
German Cancer Research Center (DKFZ)
Im Neuenheimer Feld 280
69120 Heidelberg, Baden-Württemberg
Germany
Contact person: Michael Baumann, Chairman and Scientific Director
Company main phone: +49 (6221) 420
Company main fax: +49 (6221) 422995
Website: https://www.dkfz.de
Im Neuenheimer Feld 280
69120 Heidelberg, Baden-Württemberg
Germany
Contact person: Michael Baumann, Chairman and Scientific Director
Company main phone: +49 (6221) 420
Company main fax: +49 (6221) 422995
Website: https://www.dkfz.de
| Year founded: | 1964 |
| Source of foundation: | Independent foundation |
Corporate description / mission:
German Cancer Research Center (DKFZ) provides biomedical research services for cancer in Germany. The Institute offers research on cell biology and tumor biology, functional and structural genomics, cancer risk factors and prevention, tumor immunology, imaging and radio oncology, infection and cancer, and translational cancer.
German Cancer Research Center (DKFZ) provides biomedical research services for cancer in Germany. The Institute offers research on cell biology and tumor biology, functional and structural genomics, cancer risk factors and prevention, tumor immunology, imaging and radio oncology, infection and cancer, and translational cancer.
State of ownership: Private / independent
Headquarters: HQ: Yes
Headquarters: HQ: Yes
Remarks on ownership / listings
The DKFZ was set up in 1964 by resolution of the State government of Baden-Wuerttemberg as a foundation under public law. In 1975, the Center became a member of the Association of National Research Centers.
The DKFZ was set up in 1964 by resolution of the State government of Baden-Wuerttemberg as a foundation under public law. In 1975, the Center became a member of the Association of National Research Centers.
Categorization
| Sector: |
|
| Subsector: |
|
| Primary therapeutic areas: |
|
| Business model: |
|
| Customer segments: |
|
Summary Products / Services / Technologies
Description of products:
The Center offers for licensing:
4Pi STED fluorescence light microscope with high three-Dimensional Spatial Resolution (P-1010)
Actively switched beam splitter (P-1216)
Chromatic easySTED waveplate with wide excitation range (P-1312)
Chromatic Phase Plate for Nanoscopy (P-1146)
Compact Multileaf-Collimator with small diameter (P-901)
Device for sample purification by paramagnetic beads (P-1170)
Device for stabilizing images in high resolution microscopes (P-743)
Linear Servo Multileaf Collimator for radiotherapy (P-1044)
Piezo-controlled Positioning and Driving of Multi Leaf Collimators (P-973)
Pipette device for delicate transfer of tissue in immunohistochemistry staining procedures (P-1295)
Quadscanner for High Resolution Scanning Microscopes and Array Reader (P-750)
Rapid prototyping produced patient mask for precise positioning in radiotherapy (P-806)
Stabilization of focus in high resolution microscopy (P-1260)
Temperature stabilisation of high-resolution microscopes (P-1115)
The Center offers for licensing:
4Pi STED fluorescence light microscope with high three-Dimensional Spatial Resolution (P-1010)
Actively switched beam splitter (P-1216)
Chromatic easySTED waveplate with wide excitation range (P-1312)
Chromatic Phase Plate for Nanoscopy (P-1146)
Compact Multileaf-Collimator with small diameter (P-901)
Device for sample purification by paramagnetic beads (P-1170)
Device for stabilizing images in high resolution microscopes (P-743)
Linear Servo Multileaf Collimator for radiotherapy (P-1044)
Piezo-controlled Positioning and Driving of Multi Leaf Collimators (P-973)
Pipette device for delicate transfer of tissue in immunohistochemistry staining procedures (P-1295)
Quadscanner for High Resolution Scanning Microscopes and Array Reader (P-750)
Rapid prototyping produced patient mask for precise positioning in radiotherapy (P-806)
Stabilization of focus in high resolution microscopy (P-1260)
Temperature stabilisation of high-resolution microscopes (P-1115)
© 2024 Biotechgate by Venture Valuation